Correlation Between Amgen and Pharvaris

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amgen and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and Pharvaris BV, you can compare the effects of market volatilities on Amgen and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and Pharvaris.

Diversification Opportunities for Amgen and Pharvaris

-0.84
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Amgen and Pharvaris is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Amgen i.e., Amgen and Pharvaris go up and down completely randomly.

Pair Corralation between Amgen and Pharvaris

Given the investment horizon of 90 days Amgen Inc is expected to generate 0.51 times more return on investment than Pharvaris. However, Amgen Inc is 1.95 times less risky than Pharvaris. It trades about 0.2 of its potential returns per unit of risk. Pharvaris BV is currently generating about -0.09 per unit of risk. If you would invest  25,722  in Amgen Inc on December 29, 2024 and sell it today you would earn a total of  4,973  from holding Amgen Inc or generate 19.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Amgen Inc  vs.  Pharvaris BV

 Performance 
       Timeline  
Amgen Inc 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Amgen Inc are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting technical and fundamental indicators, Amgen displayed solid returns over the last few months and may actually be approaching a breakup point.
Pharvaris BV 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Amgen and Pharvaris Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amgen and Pharvaris

The main advantage of trading using opposite Amgen and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.
The idea behind Amgen Inc and Pharvaris BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
CEOs Directory
Screen CEOs from public companies around the world
Global Correlations
Find global opportunities by holding instruments from different markets